|
|
||||||||
Microbiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Via del Giochetto, 06122 Perugia, Italy
Correspondence: Luigina Romani, M.D., Ph.D., Microbiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Via del Giochetto, 06122 Perugia, Italy. E-mail: lromani{at}unipg.it
Underlying acquired immunity to the fungus Candida albicans is usually present in adult immunocompetent individuals and is presumed to prevent mucosal colonization progressing to symptomatic infection. Exploration of immunological events leading to Candida resistance or susceptibility has indicated the central role of the innate and adaptive immune systems, the relative contribution of which may vary depending on the site of the primary infection. Nevertheless, acquired resistance to infection results from the development of Th1 responses. Cytokines produced by Th1 cells activate phagocytic cells to a candidacidal state. In contrast, cytokines produced by Th2 cells inhibit Th1 development and deactivate phagocytic effector cells. Because reciprocal influences have been recognized between innate and adaptive Th immunity, it appears that an integrated immune response determines the life-long commensalism of the fungus at the mucosal level, as well as the transition from mucosal saprophyte to pathogen.
Key Words: Th1/Th2 cells cytokines neutrophils dendritic cells fungi
This article has been cited by other articles:
![]() |
A. Coste, C. Lagane, C. Filipe, H. Authier, A. Gales, J. Bernad, V. Douin-Echinard, J.-C. Lepert, P. Balard, M.-D. Linas, et al. IL-13 Attenuates Gastrointestinal Candidiasis in Normal and Immunodeficient RAG-2-/- Mice via Peroxisome Proliferator-Activated Receptor-{gamma} Activation J. Immunol., April 1, 2008; 180(7): 4939 - 4947. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Saville, A. L. Lazzell, A. K. Chaturvedi, C. Monteagudo, and J. L. Lopez-Ribot Use of a Genetically Engineered Strain To Evaluate the Pathogenic Potential of Yeast Cell and Filamentous Forms during Candida albicans Systemic Infection in Immunodeficient Mice Infect. Immun., January 1, 2008; 76(1): 97 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nisini, A. Torosantucci, G. Romagnoli, P. Chiani, S. Donati, M. C. Gagliardi, R. Teloni, V. Sargentini, S. Mariotti, E. Iorio, et al. {beta}-Glucan of Candida albicans cell wall causes the subversion of human monocyte differentiation into dendritic cells J. Leukoc. Biol., November 1, 2007; 82(5): 1136 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chandra, T. S. McCormick, Y. Imamura, P. K. Mukherjee, and M. A. Ghannoum Interaction of Candida albicans with Adherent Human Peripheral Blood Mononuclear Cells Increases C. albicans Biofilm Formation and Results in Differential Expression of Pro- and Anti-Inflammatory Cytokines Infect. Immun., May 1, 2007; 75(5): 2612 - 2620. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Renna, S. G. Correa, C. Porporatto, C. M. Figueredo, M. P. Aoki, M. G. Paraje, and C. E. Sotomayor Hepatocellular apoptosis during Candida albicans colonization: involvement of TNF-{alpha} and infiltrating Fas-L positive lymphocytes Int. Immunol., December 1, 2006; 18(12): 1719 - 1728. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Obi, A Roy, V Bates, and C Sandy Bilateral chronic fungal dacryocystitis caused by Candida dubliniensis in a neutropenic patient. J. Clin. Pathol., November 1, 2006; 59(11): 1194 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Correa, M. C. Rodriguez-Galan, B. Salido-Renteria, R. Cano, H. Cejas, and C. E. Sotomayor High dissemination and hepatotoxicity in rats infected with Candida albicans after stress exposure: potential sensitization to liver damage Int. Immunol., December 1, 2004; 16(12): 1761 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Torosantucci, G. Romagnoli, P. Chiani, A. Stringaro, P. Crateri, S. Mariotti, R. Teloni, G. Arancia, A. Cassone, and R. Nisini Candida albicans Yeast and Germ Tube Forms Interfere Differently with Human Monocyte Differentiation into Dendritic Cells: a Novel Dimorphism-Dependent Mechanism To Escape the Host's Immune Response Infect. Immun., February 1, 2004; 72(2): 833 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Romagnoli, R. Nisini, P. Chiani, S. Mariotti, R. Teloni, A. Cassone, and A. Torosantucci The interaction of human dendritic cells with yeast and germ-tube forms of Candida albicans leads to efficient fungal processing, dendritic cell maturation, and acquisition of a Th1 response-promoting function J. Leukoc. Biol., January 1, 2004; 75(1): 117 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Spellberg, D. Johnston, Q. T. Phan, J. E. Edwards Jr., S. W. French, A. S. Ibrahim, and S. G. Filler Parenchymal Organ, and Not Splenic, Immunity Correlates with Host Survival during Disseminated Candidiasis Infect. Immun., October 1, 2003; 71(10): 5756 - 5764. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Rodriguez-Galan, C. Sotomayor, M. E. Costamagna, A. M. Cabanillas, B. S. Renteria, A. M. Masini-Repiso, and S. Correa Immunocompetence of macrophages in rats exposed to Candida albicans infection and stress Am J Physiol Cell Physiol, January 1, 2003; 284(1): C111 - C118. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pietrella, R. Mazzolla, P. Lupo, L. Pitzurra, M. J. Gomez, R. Cherniak, and A. Vecchiarelli Mannoprotein from Cryptococcus neoformans Promotes T-Helper Type 1 Anticandidal Responses in Mice Infect. Immun., December 1, 2002; 70(12): 6621 - 6627. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Wanten, M. G. Netea, T. H. Naber, J. H. Curfs, L. E. Jacobs, T. J. Verver-Jansen, and B.-J. Kullberg Parenteral Administration of Medium- but Not Long-Chain Lipid Emulsions May Increase the Risk for Infections by Candida albicans Infect. Immun., November 1, 2002; 70(11): 6471 - 6474. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bromuro, A. Torosantucci, P. Chiani, S. Conti, L. Polonelli, and A. Cassone Interplay between Protective and Inhibitory Antibodies Dictates the Outcome of Experimentally Disseminated Candidiasis in Recipients of a Candida albicans Vaccine Infect. Immun., October 1, 2002; 70(10): 5462 - 5470. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Santoni, M. Boccanera, D. Adriani, R. Lucciarini, C. Amantini, S. Morrone, A. Cassone, and F. De Bernardis Immune Cell-Mediated Protection against Vaginal Candidiasis: Evidence for a Major Role of Vaginal CD4+ T Cells and Possible Participation of Other Local Lymphocyte Effectors Infect. Immun., September 1, 2002; 70(9): 4791 - 4797. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. SCHALLER, R. MAILHAMMER, and HANS.C. KORTING Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis J. Med. Microbiol., August 1, 2002; 51(8): 672 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bozza, R. Gaziano, A. Spreca, A. Bacci, C. Montagnoli, P. di Francesco, and L. Romani Dendritic Cells Transport Conidia and Hyphae of Aspergillus fumigatus from the Airways to the Draining Lymph Nodes and Initiate Disparate Th Responses to the Fungus J. Immunol., February 1, 2002; 168(3): 1362 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brieland, D. Essig, C. Jackson, D. Frank, D. Loebenberg, F. Menzel, B. Arnold, B. DiDomenico, and R. Hare Comparison of Pathogenesis and Host Immune Responses to Candida glabrata and Candida albicans in Systemically Infected Immunocompetent Mice Infect. Immun., August 1, 2001; 69(8): 5046 - 5055. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nisini, G. Romagnoli, M. J. Gomez, R. La Valle, A. Torosantucci, S. Mariotti, R. Teloni, and A. Cassone Antigenic Properties and Processing Requirements of 65-Kilodalton Mannoprotein, a Major Antigen Target of Anti-Candida Human T-Cell Response, as Disclosed by Specific Human T-Cell Clones Infect. Immun., June 1, 2001; 69(6): 3728 - 3736. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |